
Hundreds of children in England with a rare and severe form of epilepsy are set to benefit from a new drug being rolled out on the NHS.
Fenfluramine has been recommended by the National Institute for Health and Care Excellence (Nice) for patients aged two and over with Lennox–Gastaut syndrome (LGS).